Multiple Myeloma Market Size, Share & Industry Analysis, By Drug Class (Immunomodulators, Proteasome Inhibitor, Anti-CD38 Monoclonal Antibody, Alkylating Agents, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies), and Regional Forecast, 2026-2034

Last Updated: January 19, 2026 | Format: PDF | Report ID: FBI102693

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2021-2034
Base Year	2025
Estimated Year	2026
Forecast Period	2026-2034
Historical Period	2021-2024
Unit	Value (USD billion)
Segmentation	By Drug Class Immunomodulators Proteasome Inhibitor Anti-CD38 Monoclonal Antibody Alkylating Agents Others
	By Distribution Channel Hospital Pharmacies Retail Pharmacies & Drug Stores Online Pharmacies
	By Geography North America (U.S. and Canada) Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe) Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia-Pacific) Latin America (Brazil, Mexico, and the Rest of Latin America) Middle East & Africa (South Africa, GCC, and the Rest of Middle East & Africa)